CNR1 and mantle cell lymphoma: A previous study showed that CNR1 was over expressed in Mantle Cell Lymphoma (MCL) B-cells compared to non-malignant B-cells and that targeting the endocannabinoid receptors was suggested in the treatment of MCL [22].